Don’t miss the latest developments in business and finance.

Natco Pharma launches Hepatitis C drug in Nepal

Image
Press Trust of India New Delhi
Last Updated : Oct 28 2015 | 1:28 PM IST
Natco Pharma today said it has launched generic Hepcinat LP, which is in the treatment of chronic hepatitis C infection in adults, in Nepal.
NATCO priced its generic medicine, Hepcinat LP, at Rs 25,000 for a bottle of 28 tablets in Nepal, the company said in a filing to the BSE.
Hepcinat LP is generic version of Ledipasvir and Sofosbuvir combination and is used in the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
Natco had signed a non-exclusive licensing agreement with Gilead Sciences earlier in 2015, to manufacture and sell generic versions of its chronic hepatitis C medicines, including generic version of HARVONI, in India and other 100 developing countries.
Shares of the company were trading marginally up at Rs 2,570.20 on BSE in afternoon trade.

More From This Section

First Published: Oct 28 2015 | 1:28 PM IST

Next Story